| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $38.3M | +18.8% | +46.6% |
| SG&A Expense | $7.2M | -20.4% | -34.6% |
| Operating Income | -$45.6M | -10.2% | -22.5% |
| Pre-tax Income | -$41.9M | -13.3% | -35.3% |
| Income Tax | $196K | -5.3% | -13.3% |
| Net Income | -$42.0M | -13.2% | -35.0% |
| EPS (Basic) | -$0.53 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $77.3M | -11.8% | -21.4% |
| Current Assets | $336.1M | -12.8% | -31.0% |
| Total Assets | $343.0M | -12.4% | -30.1% |
| Current Liabilities | $20.2M | +0.3% | -19.9% |
| Total Liabilities | $27.2M | -0.0% | -16.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$103.8M | — | — |
| Investing Cash Flow | $142.2M | — | — |
| Financing Cash Flow | -$25.7M | — | — |
| -20.5% |
| -43.2% |
| EPS (Diluted) | -$0.53 | -20.5% | -43.2% |
| $315.8M |
| -13.3% |
| -31.1% |